Circulating Tumour DNA Is a Biomarker of Response in Angioimmunoblastic T-Cell Lymphoma. [PDF]
Yannakou CK +8 more
europepmc +1 more source
Prognostic value of baseline body composition parameters from <sup>18</sup>F-FDG PET/CT in angioimmunoblastic T-cell lymphoma patients. [PDF]
Gong H +6 more
europepmc +1 more source
Angioimmunoblastic T-cell lymphoma: a concise overview encompassing the pathogenetic, pathological, clinical, therapeutical characteristics, and recent advances. [PDF]
Feng Y +6 more
europepmc +1 more source
Using Murine Models to Understand Tumor-Lymphoid Interactions: Spotlight on CLL and AITL
Tyler A. Herek, Christine E. Cutucache
openalex +1 more source
Outcomes and prognostic factors of alternative treatment regimens for angioimmunoblastic T-cell lymphoma: a retrospective analysis. [PDF]
Yan J +6 more
europepmc +1 more source
Real-world data on long-term outcomes in patients with T-cell lymphomas: a nationwide study of Korea. [PDF]
Baek DW +8 more
europepmc +1 more source
A case of angioimmunoblastic T-cell lymphoma mimicking angioedema. [PDF]
Zhao H, Xia Y, Su F, Chen L, Hu B.
europepmc +1 more source
Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study. [PDF]
Ruan J +25 more
europepmc +1 more source
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma. [PDF]
Bouska A +43 more
europepmc +1 more source

